Evaluation of active and passive transport processes in corneas extracted from preserved rabbit eyes

Journal of Pharmaceutical Sciences

Volumn 99, Issue 4, 2010, Pages 1921-1930

  Majumdar, Soumyajit ^a,b   Hingorani, Tushar ^a   Srirangam, Ramesh ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

In vitro models; Paracellular transport; Permeability; Tight junction; Transcellular transport; Transporters

Indexed keywords

ACICLOVIR; ALANINE; AMINO ACID TRANSPORTER; ARGININE; ESTERASE; PHENYLALANINE; QUINIDINE;

ACTIVE TRANSPORT; ANIMAL TISSUE; ARTICLE; CELL TRANSPORT; CONTROLLED STUDY; CORNEA PERMEABILITY; DRUG DIFFUSION; DRUG PENETRATION; DRUG TRANSPORT; ENUCLEATION; ENZYME ACTIVITY; MALE; NONHUMAN; PASSIVE TRANSPORT; RABBIT; TRANSCYTOSIS;

EID: 77949844978     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21979     Document Type: Article

References (37)

1. Hamalainen KM, Kananen K, Auriola S, Kontturi K, Urtti A. 1997. Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera. Invest Ophthalmol Vis Sci 38:627-634.
2. Yi X-j, Wang Y, Yu F-SX. 2000. Corneal epithelial tight junctions and their response to lipopolysaccharide challenge. Invest Ophthalmol Vis Sci 41:4093-4100.
3. Reichl S, Dohring S, Bednarz J, Muller-Goymann CC. 2005. Human cornea construct HCC-an alternative for in vitro permeation studies? A comparison with human donor corneas. Eur J Pharm Biopharm 60:305-308.
4. Reichl S, Muller-Goymann CC. 2003. The use of a porcine organotypic cornea construct for permeation studies from formulations containing befunolol hydrochloride. Int J Pharm 250:191-201.
5. Ehrhardt C, Jin-Kim K. 2008. Drug Absorption Studies: In Situ, In Vitro and In Silico Models. 1st ed., New York: Springer. p. 291-294.
6. Pels L. 1997. Organ culture: The method of choice for preservation of human donor corneas. Br J Ophthalmol 81:523-525.
7. Becker U, Ehrhardt C, Schneider M, Muys L, Gross D, Eschmann K, Schaefer UF, Lehr CM. 2008. A comparative evaluation of corneal epithelial cell cultures for assessing ocular permeability. Altern Lab Anim 36:33-44.
8. Aggarwal D, Garg A, Kaur IP. 2004. Development of a topical niosomal preparation of acetazolamide: Preparation and evaluation. J Pharm Pharmacol 56:1509-1517.
9. Babiole M, Wilhelm F, Schoch C. 2001. In vitro corneal permeation of unoprostone isopropyl (UI) and its metabolism in the isolated pig eye. J Ocul Pharmacol Ther 17:159-172.
10. Scholz M, Lin JE, Lee VH, Keipert S. 2002. Pilocarpine permeability across ocular tissues and cell cultures: Influence of formulation parameters. J Ocul Pharmacol Ther 18:455-468.
11. Lozano JS, Chay EY, Healey J, Sullenberger R, Klarlund JK. 2008. Activation of the epidermal growth factor receptor by hydrogels in artificial tears. Exp Eye Res 86:500-505.
12. Matsumoto S, Stern ME. 2000. Effect of anti-infective ophthalmic solutions on corneal cells in vitro. Adv Ther 17:148-151.
13. Panjwani N, Michalopoulos G, Song J, Zaidi TS, Yogeeswaran G, Baum J. 1990. Neutral glycolipids of migrating and nonmigrating rabbit corneal epithelium in organ and cell culture. Invest Ophthalmol Vis Sci 31:689-695.
14. Greenbaum A, Hasany SM, Rootman D. 2004. Optisol vs. dexsol as storage media for preservation of human corneal epithelium. Eye 18:519-524.
15. Hasany SM, Basu PK. 1987. Changes of MK medium during storage of human cornea. Br J Ophthalmol 71:477-483.
16. Lindstrom RL, Kaufman HE, Skelnik DL, Laing RA, Lass JH, Musch DC, Trousdale MD, Reinhart WJ, Burris TE, Sugar A, Davis RM, Hirokawa K, Smith T, Gordon JF. 1992. Optisol corneal storage medium. Am J Ophthalmol 114:345-356.
17. Stoiber J, Ruckhofer J, Lametschwandtner A, Muss W, Hitzl W, Weikinger K, Grabner G. 2001. Eurosol versus fetal bovine serum-containing corneal storage medium. Cornea 20:205-209.
18. Anand BS, Mitra AK. 2002. Mechanism of corneal permeation of L-valyl ester of acyclovir: Targeting the oligopeptide transporter on the rabbit cornea. Pharm Res 19:1194-1202.
19. Shirasaki Y. 2008. Molecular design for enhancement of ocular penetration. J Pharm Sci 97:2462-2496.
20. Jain-Vakkalagadda B, Dey S, Pal D, Mitra AK. 2003. Identification and functional characterization of a Na+-independent large neutral amino acid transporter, LAT1, in human and rabbit cornea. Invest Ophthalmol Vis Sci 44:2919-2927.
21. Jain-Vakkalagadda B, Pal D, Gunda S, Nashed Y, Ganapathy V, Mitra AK. 2004. Identification of a Na+-dependent cationic and neutral amino acid transporter, B(0,+), in human and rabbit cornea. Mol Pharm 1:338-346.
22. Katragadda S, Talluri RS, Pal D, Mitra AK. 2005. Identification and characterization of aNa+-dependent neutral amino acid transporter, ASCT1, in rabbit corneal epithelial cell culture and rabbit cornea. Curr Eye Res 30:989-1002.
23. Majumdar S, Hingorani T, Srirangam R, Gadepalli RS, Rimoldi JM, Repka MA. 2009. Transcorneal permeation of L- and D-aspartate ester prodrugs of acyclovir: Delineation of passive diffusion versus transporter involvement. Pharm Res 26:1261-1269.
24. Armstrong JM, Myers DV, Verpoorte JA, Edsall JT., 1966. Purification and properties of human erythrocyte carbonic anhydrases. J Biol Chem 241:5137-5149.
25. Dias CS, Anand BS, Mitra AK. 2002. Effect of monoand di-acylation on the ocular disposition of ganciclovir: Physicochemical properties, ocular bioreversion, and antiviral activity of short chain ester prodrugs. J Pharm Sci 91:660-668.
26. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
27. Majumdar S, Srirangam R. 2009. Solubility, stability, physicochemical characteristics and in vitro ocular tissue permeability of hesperidin: A natural bioflavonoid. Pharm Res 26:1217-1225.
28. Brown RC, Davis TP. 2002. Calcium modulation of adherens and tight junction function: A potential mechanism for blood-brain barrier disruption after stroke. Stroke 33:1706-1711.
29. Touitou E, Barry BW. 2006. Enhancement in drug delivery. 1st edition. Boca Raton, Florida: CRC Press. pp. 530-533.
30. Cereijido M, Anderson J. 2001. Tight junctions, 2nd edition. Boca Raton, Florida: CRC Press. p. 772.
31. Hatanaka T, Haramura M, Fei YJ, Miyauchi S, Bridges CC, Ganapathy PS, Smith SB, Ganapathy V, Ganapathy ME. 2004. Transport of amino acidbased prodrugs by the Na+- and Cl(-) -coupled amino acid transporter ATB0,+ and expression of the transporter in tissues amenable for drug delivery. J Pharmacol Exp Ther 308:1138-1147.
32. Gynther M, Laine K, Ropponen J, Leppanen J, Mannila A, Nevalainen T, Savolainen J, Jarvinen T, Rautio J. 2008. Large neutral amino acid transporter enables brain drug delivery via prodrugs. J Med Chem 51:932-936.
33. Jeng BH. 2006. Preserving the cornea: Corneal storage media. Curr Opin Ophthalmol 17:332-337.
34. Spencer JA, Dixon WS, Ranadive NS, Basu PK. 1977. Factors in the survival of stored corneas. Can J Ophthalmol 12:123-127.
35. Rootman DB, Wankiewicz E, Sharpen L, Baxter SA. 2007. In situ versus whole-globe harvesting of corneal tissue from remote donor sites: Effects on initial tissue quality. Cornea 26:270-273.
36. Nakamura T, Yamada M, Teshima M, Nakashima M, To H, Ichikawa N, Sasaki H. 2007. Electrophysiological characterization of tight junctional pathway of rabbit cornea treated with ophthalmic ingredients. Biol Pharm Bull 30:2360-2364.
37. Majumdar S, Hippalgaonkar K, Repka MA. 2008. Effect of chitosan, benzalkonium chloride and ethylenediaminetetraacetic acid on permeation of acyclovir across isolated rabbit cornea. Int J Pharm 348:175-178.